• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人隐匿性自身免疫性糖尿病的治疗:最佳方案是什么?

Treatment of Latent Autoimmune Diabetes in Adults: What is Best?

作者信息

Hals Ingrid K

机构信息

Department of Endocrinology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

出版信息

Curr Diabetes Rev. 2019;15(3):188-193. doi: 10.2174/1573399814666180716144429.

DOI:10.2174/1573399814666180716144429
PMID:30009709
Abstract

Latent Autoimmune Diabetes in Adults (LADA), although formally classified as Type 1 Diabetes (T1D), very often (at least in Western countries) appear clinically with Type 2 Diabetes (T2D)-like features as overweight and insulin resistance. LADA patients do not need exogenous insulin at the time they are diagnosed with diabetes, but a large percentage will within a few years develop need for such treatment. The decline in beta cell function progresses much faster in LADA than in T2D, presumably because of the ongoing autoimmune assault in LADA, and therefore necessitates insulin therapy much earlier in LADA than in T2D. Despite high prevalence of LADA (about 10% of the total diabetic population in many countries), the treatment of LADA patients is far less elucidated than is the case for T1D and T2D. Finding a treatment strategy for LADA from the time of diagnosis, that can reduce the decline of beta cell function, ensure adequate metabolic control and thereby reduce the risk of diabetic complications is thus an important clinical challenge. Conclusions from the randomized treatment studies so far do not indicate an optimal treatment strategy in LADA. This review aims to give an overview of current practices for the medical treatment of LADA as well as an update on results from recent studies on the treatment of the disease.

摘要

成人隐匿性自身免疫性糖尿病(LADA),尽管在形式上被归类为1型糖尿病(T1D),但在临床上常常(至少在西方国家)表现出与2型糖尿病(T2D)相似的特征,如超重和胰岛素抵抗。LADA患者在被诊断为糖尿病时不需要外源性胰岛素,但很大一部分患者在几年内会发展为需要这种治疗。LADA患者β细胞功能的下降比T2D患者快得多,这可能是因为LADA中持续存在自身免疫攻击,因此LADA患者比T2D患者更早需要胰岛素治疗。尽管LADA的患病率很高(在许多国家约占糖尿病总人口的10%),但与T1D和T2D相比,LADA患者的治疗方法远未得到充分阐明。因此,从诊断时起就为LADA找到一种治疗策略,以减少β细胞功能的下降,确保充分的代谢控制,从而降低糖尿病并发症的风险,是一项重要的临床挑战。迄今为止,随机治疗研究的结论并未表明LADA的最佳治疗策略。本综述旨在概述LADA的当前医学治疗方法,并更新该疾病治疗的最新研究结果。

相似文献

1
Treatment of Latent Autoimmune Diabetes in Adults: What is Best?成人隐匿性自身免疫性糖尿病的治疗:最佳方案是什么?
Curr Diabetes Rev. 2019;15(3):188-193. doi: 10.2174/1573399814666180716144429.
2
Interventions for latent autoimmune diabetes (LADA) in adults.成人潜伏性自身免疫性糖尿病(LADA)的干预措施。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD006165. doi: 10.1002/14651858.CD006165.pub2.
3
Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.成人隐匿性自身免疫性糖尿病的管理:国际专家小组的共识声明。
Diabetes. 2020 Oct;69(10):2037-2047. doi: 10.2337/dbi20-0017. Epub 2020 Aug 26.
4
Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta-analysis.西格列汀与胰岛素治疗成人隐匿性自身免疫糖尿病的疗效与安全性:系统评价与Meta 分析。
J Diabetes Investig. 2022 Sep;13(9):1506-1519. doi: 10.1111/jdi.13814. Epub 2022 May 6.
5
Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA).1 型和 2 型糖尿病家族史与成人隐匿性自身免疫性糖尿病(LADA)的风险。
Diabetes Metab. 2017 Dec;43(6):536-542. doi: 10.1016/j.diabet.2017.05.010. Epub 2017 Jun 29.
6
Interventions for latent autoimmune diabetes (LADA) in adults.成人隐匿性自身免疫性糖尿病(LADA)的干预措施。
Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD006165. doi: 10.1002/14651858.CD006165.pub3.
7
The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.韩国某大学附属医院临床科室成人隐匿性自身免疫性糖尿病(LADA)的患病率及特征及其与慢性并发症的关系。
Acta Diabetol. 2013 Apr;50(2):129-34. doi: 10.1007/s00592-010-0228-y. Epub 2010 Oct 16.
8
Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D.成人隐匿性自身免疫性糖尿病:一项正在进行的 GAD-Alum 淋巴内注射和口服维生素 D 试验的背景、安全性和可行性的初步研究。
Front Endocrinol (Lausanne). 2022 Jul 18;13:926021. doi: 10.3389/fendo.2022.926021. eCollection 2022.
9
Latent autoimmune diabetes in youth shows greater autoimmunity than latent autoimmune diabetes in adults: Evidence from a nationwide, multicenter, cross-sectional study.青少年隐匿性自身免疫糖尿病的自身免疫性高于成人隐匿性自身免疫糖尿病:来自全国多中心横断面研究的证据。
Pediatr Diabetes. 2022 Aug;23(5):578-587. doi: 10.1111/pedi.13348. Epub 2022 May 17.
10
The continuous spectrum of glycaemic variability changes with pancreatic islet function: A multicentre cross-sectional study in China.血糖变异性的连续谱随胰岛功能变化:中国多中心横断面研究。
Diabetes Metab Res Rev. 2022 Nov;38(8):e3579. doi: 10.1002/dmrr.3579. Epub 2022 Oct 25.

引用本文的文献

1
Prognosis and outcome of latent autoimmune diabetes in adults: T1DM or T2DM?成人隐匿性自身免疫性糖尿病的预后与转归:1型糖尿病还是2型糖尿病?
Diabetol Metab Syndr. 2024 Oct 7;16(1):242. doi: 10.1186/s13098-024-01479-6.
2
Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D.成人隐匿性自身免疫性糖尿病:一项正在进行的 GAD-Alum 淋巴内注射和口服维生素 D 试验的背景、安全性和可行性的初步研究。
Front Endocrinol (Lausanne). 2022 Jul 18;13:926021. doi: 10.3389/fendo.2022.926021. eCollection 2022.
3
Peptidome Analysis of Pancreatic Tissue Derived from T1DM Mice: Insights into the Pathogenesis and Clinical Treatments of T1DM.
T1DM 小鼠胰腺组织的肽组分析:对 T1DM 发病机制和临床治疗的深入了解。
Biomed Res Int. 2021 May 21;2021:9987042. doi: 10.1155/2021/9987042. eCollection 2021.
4
Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes.成人隐匿性自身免疫性糖尿病(LADA)与2型糖尿病相比的病因及发病机制
Front Physiol. 2019 Mar 26;10:320. doi: 10.3389/fphys.2019.00320. eCollection 2019.